Teherani Mehgan, Banskota Samridhi, Camacho-Gonzalez Andres, Smith Alison G C, Anderson Evan J, Kao Carol M, Crepy D'Orleans Charles, Shane Andi L, Lu Austin, Jaggi Preeti
Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA 30322, USA.
Emory University School of Medicine, Atlanta, GA 30322, USA.
Vaccines (Basel). 2021 Sep 21;9(9):1049. doi: 10.3390/vaccines9091049.
A paucity of data exists evaluating a guardian's intent to vaccinate their child against COVID-19 in the United States. We administered 102 first (April-November 2020) and 45 second (December-January 2020-2021) surveys to guardians of children (<18 years) who had a laboratory-confirmed diagnosis of COVID-19 and assessed their intent to give a COVID-19 vaccine to their child, when one becomes available. The first and second surveys of the same cohort of guardians were conducted before and following the press releases detailing the adult Pfizer-BioNTech and Moderna Phase 3 results. Both surveys included an intent-to-vaccinate question using the subjective language of "if a safe and effective vaccine" became available, and a second question was added to second surveys using the objective language of "would prevent 19 of 20 people from getting disease". When using subjective language, 24 of 45 (53%) guardians endorsed vaccine administration for their children in the first survey, which decreased to 21 (46%) in the second survey. When adding objective language, acceptance of vaccination increased to 31 (69%, = 0.03). Common reasons for declining vaccination were concerns about adverse effects and/or vaccine safety. Providing additional facts on vaccine efficacy increased vaccine acceptance. Evidence-based strategies are needed to increase pediatric COVID-19 vaccine uptake.
在美国,评估监护人让其孩子接种新冠病毒疫苗意愿的数据很少。我们对实验室确诊感染新冠病毒的18岁以下儿童的监护人进行了102次首次调查(2020年4月至11月)和45次第二次调查(2020年12月至2021年1月),并评估了他们在有新冠病毒疫苗时让孩子接种的意愿。对同一批监护人的首次和第二次调查分别在详细公布辉瑞-生物科技公司和莫德纳公司成人疫苗3期试验结果的新闻稿发布之前和之后进行。两次调查都包括一个使用“如果有安全有效的疫苗”这种主观表述的接种意愿问题,并且在第二次调查中增加了一个使用“能预防20人中的19人患病”这种客观表述的问题。使用主观表述时,在首次调查中,45名监护人中有24名(53%)支持为孩子接种疫苗,在第二次调查中这一比例降至21名(46%)。增加客观表述后,接种疫苗的接受率提高到31名(69%,P = 0.03)。拒绝接种疫苗的常见原因是担心不良反应和/或疫苗安全性。提供有关疫苗效力的更多事实可提高疫苗接受率。需要基于证据的策略来提高儿童新冠病毒疫苗的接种率。